Survival continues to increase in chronic lymphocytic leukaemia: a population‐based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016-Reference-Cited by-同舟云学术

Survival continues to increase in chronic lymphocytic leukaemia: a population‐based analysis among 20 468 patients diagnosed in the Netherlands between 1989 and 2016

Published:2020-01-20 Issue:3 Volume:189 Page:574-577
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Straten Lina¹²^ORCID,Levin Mark‐David²,Visser Otto³,Posthuma Eduardus F. M.⁴⁵,Doorduijn Jeanette K.⁶,Kater Arnon P.⁷,Dinmohamed Avinash G.¹⁶⁸^ORCID

Affiliation:

1. Department of Research and Development Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands

2. Department of Internal Medicine Albert Schweitzer Hospital Dordrecht The Netherlands

3. Department of Registration Netherlands Comprehensive Cancer Organisation (IKNL) Utrecht The Netherlands

4. Department of Internal Medicine Reinier de Graaf Hospital Delft The Netherlands

5. Department of Haematology Leiden University Medical Center Leiden The Netherlands

6. Department of Haematology Erasmus MC Cancer Institute Rotterdam The Netherlands

7. Department of Haematology Cancer Center Amsterdam Amsterdam UMC University of Amsterdam Amsterdam The Netherlands

8. Department of Public Health Erasmus University Medical Center Rotterdam The Netherlands

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.16397

Reference10 articles.

1. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.

2. Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century

3. Interpreting trends in cancer patient survival

4. Role and timing of new drugs in CLL

5. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA;Journal of Comparative Effectiveness Research;2024-02

2. Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL;Blood;2023-09-28

3. Risk of second primary malignancies in patients with chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989-2019;Blood Cancer Journal;2023-01-13

4. Diagnosis, treatment and supportive management of chronic lymphocytic leukemia: recommendations of the Dutch HOVON CLL working group;Leukemia & Lymphoma;2022-06-23

5. Long-term trends in the loss in expectation of life after a diagnosis of chronic lymphocytic leukemia: a population-based study in the Netherlands, 1989–2018;Blood Cancer Journal;2022-04-20